NCT06903845

APIXABAN App Study

The Effect of App. for Medication-check and Video-call Guided Education on APIXABAN Adherence in Patients of Atrial Fibrillation With Cardiac Disease: Randomised Control Pilot Study(APIXABAN Study)

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Dong-Ju Choi · Academic / Other
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

The aim of this clinical trial is to evaluate whether the medication reminder app and video call can improve medication adherence to apixaban in patients with AF and comorbidities. Patients with AF and comorbid heart disease taking apixaban who meet the inclusion criteria will be randomised 1:1 to a treatment arm using a medication reminder app and bi-weekly video education and a control arm using the medication reminder app alone to compare medication adherence. Patients in both groups will use the medication app, but only the treatment group will receive additional education and feedback via video call every two weeks to reinforce the use of the medication app and medication reminders with video education. The study aims to assess the change in adherence between the two groups at week 8.

Conditions

• Atrial Fibrillation

Interventions

Type	Name	Description
PROCEDURE	video call	Conduct video training every two weeks emphasizing medication adherence.
DEVICE	Medication reminder app	Medication reminder app will remind patients to take your medication.

Timeline

• Start date: 2025-03-01
• Primary completion: 2025-12-31
• Completion: 2025-12-31
• First posted: 2025-04-01
• Last updated: 2025-04-06

Locations

1 site across 1 country: South Korea